Multi-channel System for Analysis of Cardiac Rhythmicity and Conductivity In Vitro

  • Yong-Fu Xiao


The microelectrode array (MEA) technology has been widely used in academic and industrial laboratories for revealing electrical activity of multiple electrogenic cells noninvasively. Scientists use this technology to study rhythmicity and conductivity of excitable cells and to assess the biological effect and safety of new drugs. This chapter describes how to use MEA technology to assess cellular electrophysiology of multiple cardiomyocytes in vitro. The MEA technique can monitor short- or long-term electrical activity of various types of cardiomyocytes or myocardial tissues under a relatively native environment. Compared with other approaches, the MEA method has several advantages, such as assessment of electrical interactions among cardiomyocytes at multiple sites, long-term monitoring of electrophysiological changes after chemical or biological treatment, and exceptional stability of signal recordings from contracting cardiomyocytes without damaging and interfering with the cells. However, compared to the patch clamp method, the MEA approach has little controllability of intracellular components. Generally speaking, the MEA technique is a fast, easy to handle, and efficient method to study the electrophysiological activity of excitable cells or tissues.


Microelectrode Array Beating Rate Spontaneous Beating Extracellular Field Potential Cellular Electrophysiology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



I am very grateful to Alena Nikolskaya, PhD, Lepeng Zeng, PhD, Xiaohong Qin, MD, Daniel C. Sigg, MD, PhD, Eric S. Richardson, BS, and Paul A. Iaizzo, PhD for their collaboration and help.


  1. 1.
    Pine J. Recording action potentials from cultured neurons with extracellular microcircuit electrodes. J Neurosci Methods 1980; 2:19–31.PubMedCrossRefGoogle Scholar
  2. 2.
    CA Jr, Springer PA, Loeb GE, et al. A miniature microelectrode array to monitor the bioelectric activity of cultured cells. Exp Cell Res 1972; 74:61–6.CrossRefGoogle Scholar
  3. 3.
    Reppel M, Pillekamp F, Lu ZJ, et al. Microelectrode arrays: a new tool to measure embryonic heart activity. J Electrocardiol 2004; 37(Suppl):104–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Stett A, Egert U, Guenther E, et al. Biological application of microelectrode arrays in drug discovery and basic research. Anal Bioanal Chem 2003; 377:486–95.PubMedCrossRefGoogle Scholar
  5. 5.
    White SM, Constantin PE, Claycomb WC. Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am J Physiol Heart Circ Physiol 2004; 286:H823–9.PubMedCrossRefGoogle Scholar
  6. 6.
    Ludwig A, Zong X, Stieber J, et al. Two pacemaker channels from human heart with profoundly different activation kinetics. EMBO J 1999; 18:2323–9.PubMedCrossRefGoogle Scholar
  7. 7.
    Reppel M, Igelmund P, Egert U, et al. Effect of cardioactive drugs on action potential generation and propagation in embryonic stem cell-derived cardiomyocytes. Cell Physiol Biochem 2007; 19:213–24.PubMedGoogle Scholar
  8. 8.
    Caspi O, Itzhaki I, Arbel G, et al. In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes. Stem Cells Dev 2009; 18(1):161–72.PubMedCrossRefGoogle Scholar
  9. 9.
    Hescheler J, Halbach M, Egert U, et al. Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J Electrocardiol 2004; 37(Suppl):110–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Gepstein L. Experimental molecular and stem cell therapies in cardiac electrophysiology. Ann N Y Acad Sci 2008; 1123:224–31.PubMedCrossRefGoogle Scholar
  11. 11.
    Pillekamp F, Reppel M, Brockmeier K, et al. Impulse propagation in late-stage embryonic and neonatal murine ventricular slices. J Electrocardiol 2006; 39:425.e1–4.CrossRefGoogle Scholar
  12. 12.
    Hannes T, Halbach M, Nazzal R, et al. Biological pacemakers: characterization in an in vitro coculture model. J Electrocardiol 2008; 41:562–6.PubMedCrossRefGoogle Scholar
  13. 13.
    Hou YM, Na JN, Rayile A. Cardiac field potentials and activation sequence in Langendorff perfused heart, cardiac tissue slices and cultured ventricular myocytes recorded by microelectrode arrays system. Zhonghua Xin Xue Guan Bing Za Zhi 2008; 36:944–6.PubMedGoogle Scholar
  14. 14.
    Beeres SL, Atsma DE, van der Laarse A, et al. Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J Am Coll Cardiol 2005; 46:1943–52.PubMedCrossRefGoogle Scholar
  15. 15.
    Pijnappels DA, Schalij MJ, van Tuyn J, et al. Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling. Cardiovasc Res 2006; 72:282–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Pijnappels DA, Schalij MJ, Ramkisoensing AA, et al. Forced alignment of mesenchymal stem cells undergoing cardiomyogenic differentiation affects functional integration with cardiomyocyte cultures. Circ Res 2008; 103:167–76.PubMedCrossRefGoogle Scholar
  17. 17.
    Kehat I, Khimovich L, Caspi O, et al. Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol 2004; 22:1282–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Halbach M, Egert U, Hescheler J, et al. Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol Biochem 2003; 13:271–84.PubMedCrossRefGoogle Scholar
  19. 19.
    Claycomb WC, Lanson NA Jr, Stallworth BS, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998; 95:2979–84.PubMedCrossRefGoogle Scholar
  20. 20.
    Xiao YF, TenBroek EM, Wilhelm JJ, et al. Electrophysiological characterization of murine HL-5 atrial cardiomyocytes. Am J Physiol Cell Physiol 2006; 291:C407–16.PubMedCrossRefGoogle Scholar
  21. 21.
    Cicconi S, Ventura N, Pastore D, et al. Characterization of apoptosis signal transduction pathways in HL-5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model. J Cell Physiol 2003; 195:27–37.PubMedCrossRefGoogle Scholar
  22. 22.
    Wu F, Yan W, Pan J, et al. Processing of pro-atrial natriuretic peptide by corin in cardiac myocytes. J Biol Chem 2002; 277:16900–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Nikolskaya AV, Nikolski VP, Efimov IR. Gene printer: laser-scanning targeted transfection of cultured cardiac neonatal rat cells. Cell Commun Adhes 2006; 13:217–22.PubMedCrossRefGoogle Scholar
  24. 24.
    Banach K, Halbach MD, Hu P, et al. Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am J Physiol Heart Circ Physiol 2003; 284:H2114–23.PubMedGoogle Scholar
  25. 25.
    Hescheler J, Wartenberg M, Fleischmann BK, et al. Embryonic stem cells as a model for the physiological analysis of the cardiovascular system. Methods Mol Biol 2002; 185:169–87.PubMedGoogle Scholar
  26. 26.
    Caspi O, Gepstein L. Potential applications of human embryonic stem cell-derived cardiomyocytes. Ann N Y Acad Sci 2004; 1015:285–98.PubMedCrossRefGoogle Scholar
  27. 27.
    Harding SE, Ali NN, Brito-Martins M, et al. The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacol Ther 2007; 113:341–53.PubMedCrossRefGoogle Scholar
  28. 28.
    Reppel M, Pillekamp F, Brockmeier K, et al. The electrocardiogram of human embryonic stem cell-derived cardiomyocytes. J Electrocardiol 2005; 38:166–70.PubMedCrossRefGoogle Scholar
  29. 29.
    Schwanke K, Wunderlich S, Reppel M, et al. Generation and characterization of functional cardiomyocytes from rhesus monkey embryonic stem cells. Stem Cells 2006; 24:1423–32.PubMedCrossRefGoogle Scholar
  30. 30.
    Xue T, Cho HC, Akar FG, et al. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation 2005; 111:11–20.PubMedCrossRefGoogle Scholar
  31. 31.
    Lohmann H, Bussek, A, Schmidt M, et al. Isolated living heart slices from adult rats and guinea pigs as a model for drug testing. Naunyn-Schmiedebergs Arch Pharmacol 2006; 372:90 (Abstract 332).Google Scholar
  32. 32.
    Dobrzynski H, Boyett MR, Anderson RH. New insights into pacemaker activity: promoting understanding of sick sinus syndrome. Circulation 2007; 115:1921–32.PubMedCrossRefGoogle Scholar
  33. 33.
    Thollon C, Bedut S, Villeneuve N, et al. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Br J Pharmacol 2007; 150:37–46.PubMedCrossRefGoogle Scholar
  34. 34.
    Natarajan A, Molnar P, Sieverdes K, et al. Microelectrode array recordings of cardiac action potentials as a high throughput method to evaluate pesticide toxicity. Toxicol In Vitro 2006; 20:375–81.PubMedCrossRefGoogle Scholar
  35. 35.
    Meyer T, Boven KH, Gunther E, et al. Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation. Drug Saf 2004; 27:763–72.PubMedCrossRefGoogle Scholar
  36. 36.
    Igelmund P, Zhao YQ, Heinemann U. Effects of T-type, L-type, N-type, P-type, and Q-type calcium channel blockers on stimulus-induced pre- and postsynaptic calcium fluxes in rat hippocampal slices. Exp Brain Res 1996; 109:22–32.PubMedCrossRefGoogle Scholar
  37. 37.
    Pijnappels DA, van Tuyn J, de Vries AA, et al. Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts. Circulation 2007; 116:2018–28.PubMedCrossRefGoogle Scholar
  38. 38.
    Kizana E, Ginn SL, Smyth CM, et al. Fibroblasts modulate cardiomyocyte excitability: implications for cardiac gene therapy. Gene Ther 2006; 13:1611–5.PubMedCrossRefGoogle Scholar
  39. 39.
    Gaudesius G, Miragoli M, Thomas SP, et al. Coupling of cardiac electrical activity over extended distances by fibroblasts of cardiac origin. Circ Res 2003; 93:421–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Miragoli M, Gaudesius G, Rohr S. Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 2006; 98:801–10.PubMedCrossRefGoogle Scholar
  41. 41.
    Kizana E, Ginn SL, Allen DG, et al. Fibroblasts can be genetically modified to produce excitable cells capable of electrical coupling. Circulation 2005; 111:394–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Kehat I, Gepstein A, Spira A, et al. High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ Res 2002; 91:659–61.PubMedCrossRefGoogle Scholar
  43. 43.
    Feld Y, Melamed-Frank M, Kehat I, et al. Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation 2002; 105:522–9.PubMedCrossRefGoogle Scholar
  44. 44.
    Katritsis DG, Sotiropoulou PA, Karvouni E, et al. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter Cardiovasc Interv 2005; 65:321–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004; 94:92–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Katritsis DG, Sotiropoulou P, Giazitzoglou E, et al. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 2007; 9:167–71.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Cardiac Rhythm Disease ManagementMedtronic, Inc.Mounds ViewUSA

Personalised recommendations